| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Pseudoephedrine sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Fenoldopam |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Ethylnorepinephrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Levosalbutamol |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Isometheptene mucate |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephryl borate |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Phenylpropylmethylamine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Mephentermine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lergotrile |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bromocriptine mesilate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Isoprenaline sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Etafedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Racephedrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Cyclopentamine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Protokylol |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Amantadine hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Isoetarine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Apomorphine hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Ephedrine sulfate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Methylaminoheptane |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Caramiphen hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Etilefrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Norfenefrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Cathine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Methylephedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Clorprenaline |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Octopamine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Synephrine |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Pholedrine |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Oxymetazoline hydrochloride |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Lisuride maleate |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Midodrine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Alpha adrenergic receptor agonist |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Substance with central alpha adrenergic receptor agonist mechanism of action |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dipivefrine (substance) |
Is a |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Vasoconstrictor |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine (substance) |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Beta adrenergic receptor agonist |
Is a |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing alpha-2 adrenergic receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing norepinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Sympathomimetic identification |
Component |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
| Dopaminergic drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Sympathomimetic poisoning NOS |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adrenaline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Accidental adrenalin poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Intentional adrenalin poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adrenalin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Accidental norepinephrine poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Intentional noradrenaline poisoning |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Norepinephrine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Sympathomimetic adverse reaction |
Causative agent (attribute) |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
| Dopamine adverse reaction |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Xamoterol adverse reaction |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Sympathomimetic allergy |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to dipivefrin (finding) |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to dopamine |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to ephedrine (finding) |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to oxymetazoline |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to xamoterol (finding) |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Sympathomimetic overdose |
Causative agent (attribute) |
True |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
1 |
| Xamoterol fumarate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine + inotropics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine [cardiovascular use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 100micrograms/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1000micrograms/mL injection solution 0.3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 500micrograms/mL injection solution 0.3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 100micrograms/mL injection solution 10mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1mg/mL injection solution 5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine in Glucose 800micrograms/mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 40mg/mL infusion concentrate 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 160mg/mL infusion concentrate 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 40mg/mL injection solution 5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Dopamine hydrochloride 40mg/mL injection solution 10mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Xamoterol [sympathomimetic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Vasoconstrictor sympathomimetics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Norepinephrine acid tartrate 2mg/mL infusion concentrate 20mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Norepinephrine acid tartrate 2mg/mL infusion concentrate 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Norepinephrine acid tartrate 2mg/mL infusion concentrate 4mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Oxedrine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine [resp] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bronchilator inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Bronchodilators + sedative |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1:1000 1mg/mL topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by levarterenol |
Causative agent (attribute) |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine acid tartrate 0.01% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine acid tartrate 0.1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Neutral epinephrine 0.05% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Neutral epinephrine 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Neutral epinephrine 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Neutral epinephrine 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine 1:10,000 100micrograms/mL injection solution 3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing alpha adrenergic receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Noradrenaline product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Adrenaline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Epinephrine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
| Product containing xamoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sympathomimetic agent (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]